Table 3.
Variable | n = 69 (%) |
---|---|
Age (years) | |
Median (range) | 69 (40–85) |
Gender | |
Male | 60 (87) |
Female | 9 (13) |
Performance status | |
0 | 12 (17) |
1 | 46 (67) |
2 | 10 (15) |
3 | 1 (1) |
Tumor type, TNMa | |
Nasopharyngeal ca. | 5 (7) |
T1N2M0 | 1 |
T1N3M0 | 1 |
T2N1M0 | 3 |
Oropharyngeal ca. | 15 (22) |
T1N0M0 | 1 |
T1N2M0 | 4 |
T2N0M0 | 1 |
T2N1M0 | 2 |
T2N2M0 | 1 |
T3N1M0 | 1 |
T4N1M0 | 1 |
T4N2M0 | 1 |
T4N3M0 | 3 |
Hypopharyngeal ca. | 22 (32) |
T1N0M0 | 2 |
T1N2M0 | 1 |
T2N0M0 | 8 |
T2N1M0 | 1 |
T2N2M0 | 4 |
T3N2M0 | 2 |
T4N0M0 | 2 |
T4N2M0 | 2 |
Laryngeal ca. | 27 (39) |
T2N0M0 | 22 |
T2N1M0 | 1 |
T2N2M0 | 2 |
T3N0M0 | 1 |
T3N2M0 | 1 |
aInternational Union Against Cancer tumor, node, metastasis classification, 6th edition